These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2515041)

  • 1. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime.
    Korting HC; Abeck D
    Chemotherapy; 1989; 35(6):441-8. PubMed ID: 2515041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea.
    Mogabgab WJ; Lutz FB
    South Med J; 1994 Apr; 87(4):461-4. PubMed ID: 8153771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
    McCormack WM; Mogabgab WJ; Jones RB; Hook EW; Wendel GD; Handsfield HH
    Sex Transm Dis; 1993; 20(5):269-73. PubMed ID: 8235924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
    Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
    J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.
    van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M
    Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of cefotaxime and ceftriaxone in patients with uncomplicated gonorrhea.
    Jones RB; Mogabgab WJ; McCormack WM; Wendel GD
    Clin Ther; 1991; 13(5):550-6. PubMed ID: 1799912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections.
    Portilla I; Lutz B; Montalvo M; Mogabgab WJ
    Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men.
    Handsfield HH; Murphy VL
    Lancet; 1983 Jul; 2(8341):67-70. PubMed ID: 6134959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ceftriaxone as a single-dose treatment for male gonococcal urethritis].
    Urabe S; Shigematsu S
    Jpn J Antibiot; 1984 Nov; 37(11):2169-73. PubMed ID: 6098709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
    Handsfield HH; McCormack WM; Hook EW; Douglas JM; Covino JM; Verdon MS; Reichart CA; Ehret JM
    N Engl J Med; 1991 Nov; 325(19):1337-41. PubMed ID: 1922235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin. A dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.
    Eichmann A; Weidmann G; Havas L
    Chemotherapy; 1981; 27 Suppl 1():62-9. PubMed ID: 6788458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo.
    Korting HC; Neubert U
    Chemotherapy; 1984; 30(5):322-7. PubMed ID: 6092006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.
    Handsfield HH; Murphy VL; Holmes KK
    Antimicrob Agents Chemother; 1981 Dec; 20(6):839-40. PubMed ID: 6275788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in antimicrobial management of gonorrhoea by general practitioners in Amsterdam, the Netherlands, between 2010 and 2016: a cross-sectional study.
    van Amerongen R; Gazendam RP; van Bergen JEAM
    BMC Fam Pract; 2019 Jan; 20(1):12. PubMed ID: 30646849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results.
    Neubert U; Korting HC; Ruckdeschel G
    Arch Dermatol Res; 1982; 274(3-4):321-6. PubMed ID: 6299208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy.
    Haizlip J; Isbey SF; Hamilton HA; Jerse AE; Leone PA; Davis RH; Cohen MS
    Sex Transm Dis; 1995; 22(3):145-8. PubMed ID: 7652655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium.
    Mroczkowski TF; Millikan LE; Martin DH; Leonik KJ
    Drugs Exp Clin Res; 1993; 19(1):41-6. PubMed ID: 8223139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.
    Collier AC; Judson FN; Murphy VL; Leach LA; Root CJ; Handsfield HH
    Am J Med; 1984 Oct; 77(4C):68-72. PubMed ID: 6093523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cefotaxime with ceftriaxone given intramuscularly 12-hourly for community-acquired pneumonia.
    Dansey RD; Jacka PJ; Strachan SA; Hay M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):81-4. PubMed ID: 1730188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.